Skip to content

Sally Beauty SBH Free cash flow

Free cash flow at other companies

CVS Health logo
CVS HealthCVS
$3.4B-10.8%
Walmart
 logo
Walmart WMT
-$1.95B-558%
Amazon logo
AmazonAMZN
-$18.17B-127%
Olaplex Holdings, Inc. logo
Olaplex Holdings, Inc.OLPX
$7.35M+348%
Coty logo
CotyCOTY
$513.1M+22.5%
Ulta Beauty, Inc. logo
Ulta Beauty, Inc.ULTA

Other financials

Income statement

See full
Revenue$903.4M+2.3%
Gross profit$475.8M+3.7%
Operating income$71.9M+3.7%
Net income$42.7M+8.9%
EPS (diluted)$0.43+13.2%

Balance sheet

See full
Cash & equivalents$157.4M+70.8%
Total debt$1.5B-0.4%
Total equity$837.9M+19.7%
Total assets$2.9B+5.4%

Cash flow

See full
Operating cash flow$73.3M+43.5%
CapEx$29.2M+54.4%

Valuation

See full
Market cap$1.37B+45.9%
Enterprise value$2.72B+15.0%
P/E7.4×+2.4×
P/S0.4×+0.1×

Profitability

See full
Gross margin51.9%+0.6pp
Operating margin8.2%-0.5pp
Net margin4.9%-0.1pp
FCF margin6.1%+2.1pp

Returns & leverage

See full
Return on equity23.9%-5.8pp
Debt / equity1.8×-0.4×
Current ratio2.3×0.0×

Where this comes from

Calculated from Sally Beauty’s reported figures.

The official record: Sally Beauty’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sally Beauty's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sally Beauty's free cash flow?
Sally Beauty (SBH) reported free cash flow of $44.12M in Q1 2026.
How has Sally Beauty's free cash flow changed year-over-year?
Sally Beauty's free cash flow increased by 37.1% year-over-year, from $32.17M to $44.12M.
What is the long-term trend for Sally Beauty's free cash flow?
Over 4 years (2021 to 2025), Sally Beauty's free cash flow has grown at a -13.5% compound annual growth rate (CAGR), from $307.96M to $172.69M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.